Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06597279 · ClinicalTrials.gov registry record · NA
Developing Tools for Dialysis Decision Support
A NA study of Chronic Kidney Diseases, sponsored by VA Palo Alto Health Care System.
- Active
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 2
- Study locations
NCT06597279: Active NA study of Chronic Kidney Diseases, sponsored by VA Palo Alto Health Care System.
NCT06597279 is a NA study of Chronic Kidney Diseases that is active but no longer recruiting, run by VA Palo Alto Health Care System. The registered enrollment target is 25 participants, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06597279, a NA study of Chronic Kidney Diseases, is active but no longer recruiting, sponsored by VA Palo Alto Health Care System.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 2
- Study locations
Study Summary
The aim of this study is to evaluate the impact of a web-based dialysis decision support tool on decisional conflict, and values-treatment concordance and other decisional outcomes in individuals with advanced chronic kidney disease, and to assess the tool's acceptability and usability.
Primary Outcome
Proportion of patients who are undecided about treatment choice.
Conditions Studied
Interventions
- BEHAVIORAL Web-based dialysis decision support tool
Study Locations (2)
California
- U.S. Department of Veterans Affairs - Palo Alto Health Care System - Palo Alto
- Stanford Health Care - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2024-11-21 |
| Est. Completion | 2026-09 |
| Phase | NA |
What the registry record for NCT06597279 still lists
NCT06597279 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which Web-based dialysis decision support tool is the first listed.
NCT06597279 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06597279 about?
NCT06597279 is a clinical study titled "Developing Tools for Dialysis Decision Support". The aim of this study is to evaluate the impact of a web-based dialysis decision support tool on decisional conflict, and values-treatment concordance and other decisional outcomes in individuals with advanced chronic kidney disease, and to assess the tool's acceptability and usability.
What is the current status of trial NCT06597279?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-11-21. Estimated completion is 2026-09.
What conditions does trial NCT06597279 study?
This clinical trial studies the following conditions: Chronic Kidney Diseases.
What interventions are being tested in trial NCT06597279?
The interventions under investigation include: Web-based dialysis decision support tool (BEHAVIORAL).
Who is sponsoring clinical trial NCT06597279?
This trial is sponsored by VA Palo Alto Health Care System, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06597279 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06597279's enrollment target sits among peer trials
25 68th of 73 higher than 6 of 73 other Chronic Kidney Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Mindfulness in Chronic Kidney Disease
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads
RECRUITING · NA
-
Handgrip Exercise Training and CKD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI